Երկիր: Ամերիկայի Միացյալ Նահանգներ
Լեզու: անգլերեն
Աղբյուրը: NLM (National Library of Medicine)
CEFIXIME (UNII: 97I1C92E55) (CEFIXIME ANHYDROUS - UNII:XZ7BG04GJX)
Belcher Pharmaceuticals,LLC
ORAL
PRESCRIPTION DRUG
To reduce the development of drug resistant bacteria and maintain the effectiveness of Cefixime for oral suspension and other antibacterial drugs, Cefixime for oral suspension should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antimicrobial therapy. In the absence of such data,local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Cefixime for oral suspension is a cephalosporin antibacterial drug indicated in the treatment of adults and pediatric patients six months of age or older with the following infections when caused by susceptible isolates of the designated bacteria: Uncomplicated Urinary Tract Infections caused by Escherichia coli and Proteus mirabilis Otitis media caused by Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pyogenes. (Efficacy for Streptococcus py
Cefixime for oral suspension, USP is available for oral administration in following dosage forms, strengths and packages listed in the table below: Bottle of 10 mL Bottle of 20 mL 62250-668-24 62250-668-25 After reconstitution: Store at room temperature or under refrigeration. Keep tightly closed
Abbreviated New Drug Application
CEFIXIME- CEFIXIME POWDER, FOR SUSPENSION BELCHER PHARMACEUTICALS,LLC ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE CEFIXIME FOR ORAL SUSPENSION SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR CEFIXIME FOR ORAL SUSPENSION. CEFIXIME FOR ORAL SUSPENSION USP, 500 MG/5 ML FOR ORAL ADMINISTRATION INITIAL U.S. APPROVAL:1986 TO REDUCE THE DEVELOPMENT OF DRUG-RESISTANT BACTERIA AND MAINTAIN THE EFFECTIVENESS OF CEFIXIME FOR ORAL SUSPENSION, USP AND OTHER ANTIBACTERIAL DRUGS, CEFIXIME FOR ORAL SUSPENSION, USP SHOULD BE USED ONLY TO TREAT INFECTIONS THAT ARE PROVEN OR STRONGLY SUSPECTED TO BE CAUSED BY BACTERIA. INDICATIONS AND USAGE Cefixime for oral suspension, USP is a cephalosporin antibacterial drug indicated for • Uncomplicated Urinary Tract Infections ( 1.1) • Otitis Media ( 1.2) • Pharyngitis and Tonsillitis ( 1.3) • Acute Exacerbations of Chronic Bronchitis ( 1.4) • Uncomplicated Gonorrhea (cervical/urethral)( 1.5) DOSAGE AND ADMINISTRATION • Adults: 400 mg daily ( 2.1) • Children: 8 mg/kg/day ( 2.2) DOSAGE FORMS AND STRENGTHS Oral Suspension: 500 mg/5 mL (3) CONTRAINDICATIONS Contraindicated in patients with known allergy to cefixime or other cephalosporins. (4) WARNINGS AND PRECAUTIONS WARNINGS AND PRECAUTIONS • Hypersensitivity reactions including shock and fatalities have been reported with cefixime. Discontinue use if a reaction occurs. (5.1) • Clostridium difficile associated diarrhea: Evaluate if diarrhea occurs. (5.2) (5) ADVERSE REACTIONS Most common adverse reactions are gastrointestinal such as diarrhea (16%), nausea (7%), loose stools (6%), abdominal pain (3%), dyspepsia (3%), and vomiting. (6) (6) TO REPORT SUSPECTED ADVERSE REACTIONS, CONTACT BELCHER PHARMACEUTICALS, LLC AT 1-727- 471-0850 OR FDA AT 1-800-FDA-1088 OR _WWW.FDA.GOV/MEDWATCH_. (6) DRUG INTERACTIONS Elevated carbamazepine levels have been reported in postmarketing experience when cefixime is administered concomitantly. (7.1) Increased prot Կարդացեք ամբողջական փաստաթուղթը